UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

UnitedHealth Group Incorporated

Tuesday, September 9, 2025
A series of big events today, on what had been expected to be fairly mild in actionablemarket news actually kicked off late yesterday with news that Amsterdam-based GPU creator Nebius NBIS is engaging in an AI infrastructure deal with Microsoft MSFT worth $17.4 billion through 2031. Shares of the former spinoff from Russian tech giant Yandex shot up +49% today.
UnitedHealth UNH was the Dow’s biggest mover today, +8.5%, on news that 78% of its Medicare Advantage enrollees should qualify for bonus payments from the federal government. These include plans rated 4-stars or higher. UNH shares remain down -31% year to date.
Apple’s AAPL iPhone 17 event — today’s unveiling of the slimmer iPhone Air model — failed to prod investors toward buying the stock. Though the sleek design may be a selling point for some customers, the lack of any major enhancements with AI technology, etc. Shares of AAPL were down -1.5% today, even as the Nasdaq closed at new all-time high.
The Dow finished the day up +196 points, +0.43%, while the S&P 500 gained +17 points, +0.27%. The Nasdaq’s record day took it to 21,879, up +80 points on the session, +0.37%. The small-cap Russell 2000 was the only major index to give back recent gains today: -13 points or -0.55%.
Oracle Misses in Q3, Stock Shoots Up +22%
After today’s close, Oracle ORCL reported lackluster earnings in its fiscal Q3 report today: earnings of $1.47 per share just met the Zacks consensus, while revenues of $14.93 billion missed expectations of $15.01 billion. Yet shares have zoomed ahead +22% upon the release as its cloud revenue growth has gone into a new orbit.
Without getting too deep into the weeds, Oracle services excess cloud demand for other Big Tech players, such as Microsoft, Amazon, Google, etc. And business has been booming: Cloud Infrastructure grew +55% year over year to $3.3 billion, Remaining Performance Obligations (RPO) backlog gained +359%, and Multi-cloud Database Revenue expanded +1529% from a year ago. These aren’t the high-margin businesses that serve organic Oracle customers, but it’s hard to argue with +1500% growth.
New Jobs Revisions Drop -911K in a Year
Last year, when 12-month revisions to employment numbers from the U.S. Bureau of Labor Statistics (BLS) came out, it demonstrated a massive disconnect with initial job reportage, to the tune of -818K. (This was subsequently revised to -598K at a later date.) It turns out this extraordinarily high number was not a one-off: today’s 12-month BLS revision was -911K — the largest such revision ever.
This accounted for the year from April 2024 through March 2025, which saw the highest number of jobs reduced per sector in the Leisure & Hospitality space, -176K. Professional/Business Services dialed back job gains by -158K for that time period, Trade Retail subtracted -126K and Trade Wholesale shed -110K. Trade/Transportation/Utilities grew +6600 jobs and Utilities gained +3700 on the revision.
These revisions depict the antiquated method of telephone surveys to gather jobs data. Last month, President Trump fired the Director of BLS because he said the jobs numbers were “rigged.” The White House doubled-down on this sentiment following the data’s release today without mentioning that jobs numbers since March of this year have taken yet another step lower. Trump’s choice to take over as BLS Director is E.J. Antoni, who hails from the right-wing think tank The Heritage Foundation.
What to Expect from the Stock Market Tomorrow
The big report we are looking at Wednesday morning is the August Producer Price Index (PPI) — the wholesale side of inflation in the U.S. economy. Headline PPI month over month is expected to come way down to +0.3% from +0.9% reported in July. On core (subtracting volatile food and energy prices) we’re also looking for +0.3% month over month, down from +0.6% the previous month.
Year over year PPI was getting heated up in July: +3.3%, +2.8% on core. With these monthly figures likely to cool, perhaps we’ll see some relief on these year-over-year numbers as well. But 3% PPI inflation is as good a reason as any for the Fed not to have begun making interest rate cuts yet this year. These numbers cooling tomorrow would go a long way to assuage the Fed’s fears.
We can already see there is good reason to cut rates with jobs production now averaging just +70K per month. (And that doesn’t count August’s +22K and June’s -13K.) These levels do not likely cover the number of retirees among the U.S. labor force per month, to say nothing of the effects that ICE raids are having on domestic employment. The Fed meets on monetary policy a week from today, with a new interest rate level reporting next Wednesday at 2pm ET.
Questions or comments about this article and/or author? Click here>>
Quantum Computing Stocks Set To Soar
Artificial intelligence has already reshaped the investment landscape, and its convergence with quantum computing could lead to the most significant wealth-building opportunities of our time.
Today, you have a chance to position your portfolio at the forefront of this technological revolution. In our urgent special report, Beyond AI: The Quantum Leap in Computing Power, you'll discover the little-known stocks we believe will win the quantum computing race and deliver massive gains to early investors.
Access the Report Free Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Oracle Misses in Q3, Gains +22% - Plus Jobs Revisions & More

The S&P 500 (SNPINDEX: ^GSPC) rose 0.27% to 6,512.61 on Tuesday, marking another record close. The Nasdaq Composite (NASDAQINDEX: ^IXIC) gained 0.37% to 21,879.49, while the Dow Jones Industrial Average (DJINDICES: ^DJI) climbed 0.43%, to 45,711.34. The broad advance extended a September rally fueled by expectations of a Federal Reserve rate cut.
Revised payroll data showed that U.S. job growth was weaker than previously estimated, with a downward adjustment of more than 900,000 positions through March. While slower labor momentum reflects economic cooling, it also reinforced hopes that the Fed may ease policy later this year. That backdrop, coupled with anticipation for inflation reports due this week, supported fresh highs across the major benchmarks.
On the corporate side, healthcare names outperformed, led by UnitedHealth Group Inc. (NYSE: UNH), while Nebius Group (NASDAQ: NBIS) surged nearly 50% after announcing an AI infrastructure partnership with Microsoft Corp. (NASDAQ: MSFT). Investors now look to the upcoming CPI and PPI reports for confirmation that price pressures are easing before the Fed's next meeting.
Should you invest $1,000 in S&P 500 Index right now?
Before you buy stock in S&P 500 Index, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and S&P 500 Index wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $671,288!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,031,659!*
Now, it’s worth noting Stock Advisor’s total average return is 1,056% — a market-crushing outperformance compared to 185% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of September 8, 2025
Daily Stock News has no position in any of the stocks mentioned. This article was generated with GPT-5, OpenAI's large-scale language generation model and has been reviewed by The Motley Fool's AI quality control systems. The Motley Fool has positions in and recommends Microsoft. The Motley Fool recommends Nebius Group and UnitedHealth Group and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Stock Market Today: All Three Indexes Close at Record Highs Amid Rate-Cut Optimism

Key Points
A regulatory filing revealed UnitedHealth is on target to meet its Medicare Advantage enrollment targets.
The insurer's bottom line is directly affected by the quality of plans enrollees choose.
UnitedHealth still faces multiple DOJ probes and allegations of misconduct.
Shares of UnitedHealth Group (NYSE: UNH) are rising on Tuesday, up 8.8% as of 2:23 p.m. ET. The jump comes as the S&P 500 and the Nasdaq Composite ticked up slightly.
The struggling healthcare giant's stock is spiking after it submitted a regulatory filing that suggests it is on track to hit targets for its premium plan enrollment, despite its recent troubles.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
UnitedHealth hits Medicare Advantage targets
The company's data shows 78% of its Medicare Advantage members will be enrolled in plans with quality ratings of at least four stars next year. That's the target laid out by former CEO Andrew Witty this summer that many investors feared UnitedHealth would fail to meet.
The company's revenue is directly tied to the star level of its enrollees: Better plans earn UnitedHealth more money. The figure isn't very impressive on its own -- it's in line with the average from past years -- but considering how much the insurer has been struggling to meet targets, it's a positive sign in the company's ongoing efforts to right the ship.
UnitedHealth's troubles are far from over
Still, UnitedHealth continues to face mounting troubles. It lost its CEO this summer for "personal reasons," it is the subject of multiple ongoing DOJ probes into misconduct and fraud, and it has been accused of offering bonuses to nursing homes to incentivize denying seniors necessary hospital care.
Healthcare costs are ballooning and proving hard to predict. While a turnaround is very possible in the long term, this company's troubles seem far from over to me. I would stay away from UnitedHealth stock.
Should you invest $1,000 in UnitedHealth Group right now?
Before you buy stock in UnitedHealth Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $671,288!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,031,659!*
Now, it’s worth noting Stock Advisor’s total average return is 1,056% — a market-crushing outperformance compared to 185% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of September 8, 2025
Johnny Rice has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Why UnitedHealth Stock Is Soaring Today

The Tema S&P 500 Historical Weight ETF Strategy is seeing unusually high volume in afternoon trading Tuesday, with over 238,000 shares traded versus three month average volume of about 26,000. Shares of DSPY were trading flat on the day.
Components of that ETF with the highest volume on Tuesday were Nvidia, trading trading flat with over 78.9 million shares changing hands so far this session, and Palantir Technologies, up about 3.4% on volume of over 40.2 million shares. UnitedHealth Group is the component faring the best Tuesday, up by about 8.2% on the day, while Albemarle is lagging other components of the Tema S&P 500 Historical Weight ETF Strategy, trading lower by about 10.8%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tuesday's ETF with Unusual Volume: DSPY

In early trading on Tuesday, shares of UnitedHealth Group topped the list of the day's best performing components of the S&P 500 index, trading up 3.1%. Year to date, UnitedHealth Group has lost about 34.7% of its value.
And the worst performing S&P 500 component thus far on the day is Albemarle, trading down 12.7%. Albemarle is lower by about 16.8% looking at the year to date performance.
Two other components making moves today are Fox, trading down 6.1%, and Valero Energy, trading up 3.0% on the day.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

S&P 500 Movers: ALB, UNH

A look at the weighted underlying holdings of the First Trust Health Care AlphaDEX Fund (Symbol: FXH) shows an impressive 10.2% of holdings on a weighted basis have experienced insider buying within the past six months.
UnitedHealth Group Inc (Symbol: UNH), which makes up 1.73% of the First Trust Health Care AlphaDEX Fund (Symbol: FXH), has seen 5 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $15,927,662 worth of UNH, making it the #22 largest holding. The table below details the recent insider buying activity observed at UNH:
UNH — last trade: $320.25 — Recent Insider Buys:
Also see:
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

First Trust Health Care AlphaDEX Fund -- Insider Buying Index Registering 10.2%

The NASDAQ 100 Pre-Market Indicator is up 62.68 to 23,824.98. The total Pre-Market volume is currently 111,870,106 shares traded.
The following are the most active stocks for the pre-market session:
Big Tree Cloud Holdings Limited (DSY) is +5.58 at $6.60, with 25,466,779 shares traded.
Opendoor Technologies Inc (OPEN) is +0.0801 at $6.12, with 13,362,315 shares traded. OPEN's current last sale is 644.22% of the target price of $0.95.
Nebius Group N.V. (NBIS) is +34.82 at $98.88, with 5,029,387 shares traded. As reported by Zacks, the current mean recommendation for NBIS is in the "buy range".
Direxion Daily TSLA Bull 2X Shares (TSLL) is +0.1 at $13.26, with 4,220,212 shares traded. This represents a 110.81% increase from its 52 Week Low.
iShares Ethereum Trust (ETHA) is +0.57 at $33.03, with 2,815,416 shares traded. This represents a 200.55% increase from its 52 Week Low.
NVIDIA Corporation (NVDA) is +0.77 at $169.08, with 2,406,874 shares traded. Over the last four weeks they have had 9 up revisions for the earnings forecast, for the fiscal quarter ending Oct 2025. The consensus EPS forecast is $1.16. As reported by Zacks, the current mean recommendation for NVDA is in the "buy range".
UnitedHealth Group Incorporated (UNH) is +12.35 at $332.60, with 2,244,208 shares traded. As reported by Zacks, the current mean recommendation for UNH is in the "buy range".
Teck Resources Ltd (TECK) is +6.34 at $41.45, with 2,074,978 shares traded. As reported by Zacks, the current mean recommendation for TECK is in the "buy range".
Alibaba Group Holding Limited (BABA) is +3.81 at $145.01, with 1,404,697 shares traded. As reported by Zacks, the current mean recommendation for BABA is in the "buy range".
QuantumScape Corporation (QS) is +0.32 at $9.81, with 1,348,131 shares traded. QS's current last sale is 159.51% of the target price of $6.15.
NIO Inc. (NIO) is -0.04 at $6.13, with 988,188 shares traded. NIO's current last sale is 111.45% of the target price of $5.5.
Carvana Co. (CVNA) is unchanged at $372.73, with 780,538 shares traded. As reported by Zacks, the current mean recommendation for CVNA is in the "buy range".
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Pre-Market Most Active for Sep 9, 2025 : DSY, OPEN, NBIS, TSLL, ETHA, NVDA, UNH, TECK, BABA, QS, NIO, CVNA

The largest health insurer in the United States, UnitedHealth Group Incorporated UNH, is increasingly incorporating artificial intelligence (AI) into its operations to transform the way healthcare is provided and managed. With its extensive data from insurance claims, provider networks and patient interactions, the company is able to implement AI tools on a large scale.
As costs continue to climb and patient expectations evolve, UNH is integrating AI into both its insurance and care delivery sectors, with the goal of boosting efficiency while enhancing patient outcomes at the same time. AI-powered systems are making it easier for healthcare providers to spot high-risk patients sooner, customize care plans and cut down on hospital admissions.
In the space of insurance, AI is playing a crucial role for UNH by making claims processing smoother and spotting fraud with high accuracy. Internal analysis of the company found that the system could save around 4,500 to 5,000 staff hours each year by cutting down on the time spent searching for information.
However, the healthcare sector is deeply rooted in human judgment, and concerns like data privacy, algorithmic bias and the risk of becoming overly dependent on automation can’t be overlooked. If UNH can strike a balance between innovation and trust, ensuring that AI tools are transparent and supportive rather than replacing healthcare professionals’ decisions, it could serve as a blueprint for the broader healthcare system while supporting the company’s long-term growth through cost reduction.
How Are Competitors Faring?
Some of UNH’s major competitors in the AI-enabled healthcare solutions are Elevance Health, Inc. ELV and Humana Inc. HUM.
Elevance Health’s AI tool speeds up the prior authorization process by aligning necessary documentation with medical policies, helping patients receive faster approvals. Elevance Health’s system undergoes thorough evaluations to check for bias and performance.
Humana focuses on using AI ethically to improve patient experiences, enhance care quality and achieve better health outcomes, while ensuring human involvement in all clinical decision-making processes. By partnering with Google Cloud, Humana utilizes Health Insurance Portability and Accountability Act-compliant infrastructure and a secure data system, allowing customers to maintain complete control over their data.
UnitedHealth’s Price Performance, Valuation & Estimates
Shares of UNH have declined 37.7% in the year-to-date period compared with the industry’s fall of 29.5%.
Image Source: Zacks Investment Research
From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 18.44, above the industry average of 15.23. UNH carries a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for UnitedHealth’s 2025 earnings is pegged at $16.21 per share, implying a 41.4% drop from the year-ago period.
Image Source: Zacks Investment Research
The stock currently carries a Zacks Rank #5 (Strong Sell).
Zacks Names #1 Semiconductor Stock
This under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.
With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.
See This Stock Now for Free >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Elevance Health, Inc. (ELV) : Free Stock Analysis Report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

UnitedHealth & AI: Can Technology Redefine Healthcare Efficiency?

Key Points
UnitedHealth shares are up 14% as of Sept. 4 since a mid-August filing revealed that Berkshire Hathaway had bought 5 million shares.
The health insurer giant faces several problems, from rising medical costs to a Justice Department investigation.
The company just hiked its dividend by 5.2% and grew Q2 revenues by 13%.
For decades, UnitedHealth Group (NYSE: UNH) could do no wrong. The company raised its dividend by an exceptional 7,266% from 2010 to 2025, while shares rose as much as 1,700% during this run.
But shares have fallen roughly 40% year to date as the company faces a host of problems, from the murder of Brian Thompson, CEO of major business segment UnitedHealthcare, to federal investigations into allegedly fraudulent Medicare billing practices.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Nonetheless, shares surged 12% on Aug. 14 after filings revealed Berkshire Hathaway had bought over 5 million shares.
Berkshire's move was seen as a major vote of confidence in the stock -- and investors joined a stampede to follow Warren Buffett into the trade. Should you?
Big growth potential for all segments
UnitedHealth operates through four segments. Its UnitedHealthcare segment provides consumer-oriented health benefit plans and services for employers. Optum Health provides healthcare management and financial services, while Optum Insight offers data analysis tools, consulting, and tech solutions to healthcare providers. Optum Rx is a direct-to-consumer platform offering pharmacy services and 190 million prescriptions per year to U.S. homes.
In its second-quarter report on July 29, the company reported quarterly revenue of $111.6 billion, up roughly 13% from the year-ago period. The trouble is with margins. For UnitedHealthcare, the biggest segment, operating margin fell from 6.2% in Q1 2025 to 2.4% last quarter. Combined, margin for the three Optum segments fell from 6.1% in Q1 2025 to 4.6% in Q2.
These declines are steep enough that, even with revenue on the upswing, earnings fell from $9.1 billion in Q1 2025 to $5.2 billion last quarter.
Rising medical costs are the chief headwind. In the July earnings report, new CEO Stephen Hensley acknowledged that UNH "significantly underestimated the accelerating medical trend," and medical costs totaled $6.5 billion more than anticipated.
But management is under no such illusions now. They're taking actions to boost efficiency and cut waste, from stepping up audits of clinical policy and payment integrity tools, to scaling artificial intelligence (AI) efforts to improve provider and patient experiences while driving down costs. Implementation of AI technologies is part of initiatives the company hopes can deliver almost $1 billion in cost reductions. Perhaps most significantly, the company is raising premiums after saying it underpriced Medicare Advantage plans in 2025.
In the meantime, each of these segments could grow significantly in the years ahead. UnitedHealthcare Employer & Individual just rolled out services in its 30th state, while Optum Rx's growth outlook is 5%-8% annually. Optum Insight is targeting operating margin of 18%-22%, while the 4.7 million patients receiving value-based care from OptumHealth represent only a fraction of the nearly 340 million Americans who could fall under its 100-plus health plans.
It's not just Berkshire buying
Berkshire Hathaway's move in UnitedHealth is getting headlines. But billionaire David Tepper also scooped up 2.3 million shares, while Michael Burry of The Big Short fame bought 350,000 call options on the stock in a bet that shares would rise.
In addition, BlackRock, the world's biggest asset manager, bought over 1 million shares last quarter. Goldman Sachs bought over 1.1 million shares, while Renaissance Technologies (the fabled fund that achieved an average annual return of 66% for decades) bought over 1.35 million.
As for management, Stephen Hensley invested $25 million just days after becoming CEO, while the company's CFO bought another $5 million worth in shares. All told, the insider buying of UNH stock outweighed insider selling by a nearly 4:1 margin last quarter.
As the investing legend Peter Lynch observed, insiders can sell for many reasons unrelated to a stock. But they buy for only one: They think shares will go up.
Why UnitedHealth is a buy for retail investors, too
Berkshire officials haven't commented publicly on their rationale for buying UnitedHealthcare, but it's possible to speculate on their reasons.
Warren Buffett has called cash flow the most important metric in assessing a business's potential. In a 2000 letter to shareholders, he wrote that dividend yield, the price-to-earnings ratio, book value, and even growth rates "have nothing to do with valuation except to the extent they provide clues to the amount and timing of cash flows into and from the business."
Positive cash flow shows the company can cover its obligations, return money to shareholders, and potentially pursue growth and expansion. After floundering in 2024, UnitedHealth's trailing-12-month operating cash flow has rebounded to $29 billion compared to $24.2 billion at the end of last year.
And if price-to-earnings, dividend yield, and growth rates are only background clues to cash flow, these metrics seem to bode well for UnitedHealth, too.
The company's price-to-earnings ratio of 13.7 is cheap compared to the S&P 500,
with its average P/E ratio of around 26, while revenue growth of 13% year over year further fuels the bull case. Meanwhile, the company's recent 5.2% dividend increase -- its 15th consecutive annual payout hike -- brings its yield to 2.8% as I write this, nearly triple the S&P 500 average.
For investors willing to take a long-term approach and be rewarded with rising income in the meantime, UnitedHealth is a buy.
Should you invest $1,000 in UnitedHealth Group right now?
Before you buy stock in UnitedHealth Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $670,781!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,023,752!*
Now, it’s worth noting Stock Advisor’s total average return is 1,052% — a market-crushing outperformance compared to 185% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of September 8, 2025
William Dahl has no positions in the stocks mentioned in this article. The Motley Fool has positions in and recommends Berkshire Hathaway and Goldman Sachs Group. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Berkshire Hathaway Buys UnitedHealth Shares: Should You Follow Suit?

Explore the exciting world of UnitedHealth (NYSE: UNH) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
*Stock prices used were the prices of Aug. 6, 2025. The video was published on Sep. 5, 2025.
Should you invest $1,000 in UnitedHealth Group right now?
Before you buy stock in UnitedHealth Group, consider this:
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $678,148!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,052,193!*
Now, it’s worth noting Stock Advisor’s total average return is 1,065% — a market-crushing outperformance compared to 186% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of August 25, 2025
Anand Chokkavelu, CFA has no position in any of the stocks mentioned. Karl Thiel has no position in any of the stocks mentioned. Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.